GMPharma Consult ApS — Credit Rating and Financial Key Figures
CVR number: 42760137
Lyngbakken 42, Alsønderup 3400 Hillerød
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | 806.88 | |
| External services | -6.30 | -14.20 |
| Gross profit | 720.33 | -14.20 |
| Costs of management | -79.95 | |
| Employee benefit expenses | -0.31 | |
| EBIT | 131.94 | -14.51 |
| Other financial expenses | -2.57 | -1.52 |
| Pre-tax profit | 129.38 | -16.03 |
| Income taxes | -28.87 | 3.18 |
| Net earnings | 100.51 | -12.84 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Long term receivables total | ||
| Inventories total | ||
| Current amounts owed by group member comp. | 3.30 | |
| Current other receivables | 0.14 | |
| Current deferred tax assets | 3.18 | |
| Short term receivables total | 0.14 | 6.48 |
| Cash and bank deposits | 173.47 | 159.97 |
| Cash and cash equivalents | 173.47 | 159.97 |
| Balance sheet total (assets) | 173.61 | 166.46 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Retained earnings | 100.51 | |
| Profit of the financial year | 100.51 | -12.84 |
| Shareholders equity total | 140.51 | 127.66 |
| Provisions | -28.87 | |
| Non-current deferred tax liabilities | 28.87 | |
| Non-current liabilities total | 28.87 | |
| Current trade creditors | 4.23 | 8.63 |
| Short-term deferred tax liabilities | 28.87 | 0.00 |
| Other non-interest bearing current liabilities | 30.16 | |
| Current liabilities total | 33.10 | 38.79 |
| Balance sheet total (liabilities) | 173.61 | 166.46 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.